NASDAQ:SION | News | Sionna Therapeutics, Inc.

SION News

Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.

DateTypePublisherHeadlineSummary
2026-08-10Current reportSEC filingSionna Therapeutics, Inc. filed Form 8-KSionna Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2026-08-06Current reportSEC filingSionna Therapeutics, Inc. filed Form 8-KSionna Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2026-06-18Current reportSEC filingSionna Therapeutics, Inc. filed Form 8-KSionna Therapeutics, Inc. filed Form 8-K covering items 5.07.
2026-05-12Current reportSEC filingSionna Therapeutics, Inc. filed Form 8-KSionna Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2026-03-02Current reportSEC filingSionna Therapeutics, Inc. filed Form 8-KSionna Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2025-11-05Current reportSEC filingSionna Therapeutics, Inc. filed Form 8-KSionna Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2025-08-11Current reportSEC filingSionna Therapeutics, Inc. filed Form 8-KSionna Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2025-06-13Current reportSEC filingSionna Therapeutics, Inc. filed Form 8-KSionna Therapeutics, Inc. filed Form 8-K covering items 5.07.
2025-06-04Current reportSEC filingSionna Therapeutics, Inc. filed Form 8-KSionna Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01.
2025-05-12Current reportSEC filingSionna Therapeutics, Inc. filed Form 8-KSionna Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2025-03-20Current reportSEC filingSionna Therapeutics, Inc. filed Form 8-KSionna Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2025-02-10Current reportSEC filingSionna Therapeutics, Inc. filed Form 8-KSionna Therapeutics, Inc. filed Form 8-K covering items 5.03,9.01.